In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020
- DOI
- 10.1016/j.ijantimicag.2023.106772
- Published
- 2023-05
- Container
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijantimicag.2023.106772,
title = {In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020},
author = {James A. Karlowsky and Sibylle H. Lob and Fakhar Siddiqui and Brune Akrich and C. Andrew DeRyke and Katherine Young and Mary R. Motyl and Stephen P. Hawser and Daniel F. Sahm},
year = {2023},
journal = {International Journal of Antimicrobial Agents},
doi = {10.1016/j.ijantimicag.2023.106772},
url = {https://doi.org/10.1016/j.ijantimicag.2023.106772}
}RIS
TY - JOUR TI - In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020 AU - James A. Karlowsky AU - Sibylle H. Lob AU - Fakhar Siddiqui AU - Brune Akrich AU - C. Andrew DeRyke AU - Katherine Young AU - Mary R. Motyl AU - Stephen P. Hawser AU - Daniel F. Sahm PY - 2023 JO - International Journal of Antimicrobial Agents DO - 10.1016/j.ijantimicag.2023.106772 UR - https://doi.org/10.1016/j.ijantimicag.2023.106772 ER -
APA
Karlowsky, J. A., Lob, S. H., Siddiqui, F., Akrich, B., DeRyke, C. A., Young, K., Motyl, M. R., Hawser, S. P., & Sahm, D. F. (2023). In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2023.106772
Source records
- crossref · retrieved 2026-09-27T02:07:49.368Z